We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sensitive Method Detects Early Amyloidosis in Humans

By LabMedica International staff writers
Posted on 03 Apr 2016
The amyloidoses comprise a large group of diseases characterized by extracellular deposits in various tissues and organs. More...
These deposits, termed “amyloid,” result from misfolding and/or partial unfolding of proteins followed by their ordered aggregation into amyloid fibrils with specific β-sheet conformation.

Diagnosis of amyloidosis requires a tissue biopsy and the biopsy is assessed for evidence of characteristic amyloid deposits. The most useful stain in the diagnosis of amyloid is Congo red, which, combined with polarized light, makes the amyloid proteins appear apple-green on microscopy.

Scientists at the Linköping University (Sweden) and their colleagues identified patients diagnosed with amyloidosis in the amyloid collection of Uppsala Biobank (Sweden). They chose 53 paraffin-embedded tissue blocks with noticeable amyloid deposits from 50 patients. A second set of amyloid specimens was retrieved and included 61 paraffin-embedded tissue blocks with conspicuous amyloid deposits from 61 patients, including 24 women and 37 men. A control set of eight tissue samples were retrieved from five patients aged 69 to 78 years, comprising heart, liver and kidney. Tissues from a control group of 27, included kidney, stomach, heart, lung, ovary, pancreas and duodenum, which showed no interstitial amyloid deposits as assessed by Congo red staining and polarization microscopy.

Archived paraffin-embedded formalin fixed sections were processed and stained with a luminescent conjugated oligothiophene, h-FTAA, that stains rapidly and with high sensitivity and selectivity detects amyloid deposits in verified clinical samples from systemic amyloidosis patients with AA, AL and ATTR types; as well as in tissues laden with localized amyloidosis of AANF, AIAPP and ASem1 type. For the archived paraffin-embedded formalin fixed tissue specimens as well as dried fine needle aspired (FNA) abdominal fat biopsies it was found that a 1:5,000 staining solution corresponding to 0.2 mg/L of h-FTAA was optimal. Fluorescence images and spectra were recorded with a Leica DM6000 B fluorescence microscope (Leica Microsystems; Wetzlar, Germany).

The probe h-FTAA emitted yellow red fluorescence on binding to amyloid deposits, whereas no apparent staining was observed in surrounding tissue. The only functional structure stained with h-FTAA showing the amyloidotypic fluorescence spectrum was Paneth cell granules in intestine. Screening of 114 amyloid containing tissues derived from 107 verified (Congo red birefringence and/or immunohistochemistry) amyloidosis patients revealed complete correlation between h-FTAA and Congo red fluorescence. The majority of Congo red negative control cases (27 of 32, 85% specificity) were negative with h-FTAA. Small Congo red negative aggregates in kidney, liver, pancreas and duodenum were found by h-FTAA fluorescence in five control patients aged 72–83 years suffering from diverse diseases.

The authors concluded that conclude that h-FTAA is a fluorescent hypersensitive, rapid and powerful tool for identifying amyloid deposits in tissue sections. Use of h-FTAA can be exploited as a rapid complementary technique for accurate detection of amyloid in routine surgical pathology settings. The results also implicate the potential of the technique for detection of prodromal amyloidosis as well as for discovery of new amyloid-like protein aggregates in humans. The study was published on March 17, 2016, in Amyloid: The Journal of Protein Folding Disorders.

Related Links:

Linköping University
Leica Microsystems



Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
All-in-One Molecular System
AIO M160
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researchers from the Department of Chemistry at Aarhus University have developed and tested a new technology that can identify and measure the concentration of pharmaceuticals in under 10 minutes. Today, this process takes up to an hour. That is critical waiting time for patients suffering from a stroke. (Image Credit: Aarhus University)

Point-of-Care Blood Test Could Speed Treatment Decisions in Acute Stroke

Minutes can shape treatment decisions in emergency stroke care, particularly when physicians need to know whether a patient is taking anticoagulants before administering clot-dissolving therapy.... Read more

Microbiology

view channel
Image: The clearance also broadens QIAstat-Dx\'s infectious disease testing menu in the U.S., which already includes panels for respiratory and gastrointestinal infections, as well as meningitis and encephalitis (Photo courtesy of Qiagen)

One-Hour Molecular Panel Expands Bloodstream Infection Testing for Gram-Negative Pathogens

Bloodstream infections can progress rapidly and lead to sepsis, organ failure, and death. In the United States, about 1.7 million adults develop sepsis each year, and at least 350,000 die during hospitalization... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.